The invention relates to compositions and methods for modulating the expression of Nogo-L or Nogo-R genes, and more particularly to the downregulation of Nogo-L or Nogo-R by chemically modified oligonucleotides.

 
Web www.patentalert.com

< Method for modulating nod1 activity, use of a mtp related molecule for modulating nod1 activity, and therapeutic applications thereof

< Treatment of vision disorders using electrical, light, and/or sound energy

> Chemically modified double stranded nucleic acid molecules that mediate RNA interference

> RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)
~ 00291